Clinical Trials Directory

Trials / Completed

CompletedNCT06575972

A Clinical Study to Assess the Effects of JoyRise Recovery Powder on Mitigating Alcohol Aftereffects.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Joyrise · Industry
Sex
All
Age
35 Years – 54 Years
Healthy volunteers
Accepted

Summary

This study assesses the effectiveness of JoyRise Recovery Powder in reducing alcohol aftereffects, cognitive impairment, and anxiousness among participants aged 35-54 who consume alcohol. Participants will be randomly assigned to either the JoyRise group or a placebo group. The study will measure hangover symptoms, cognitive function, and overall well-being through a series of questionnaires and cognitive tests at baseline, 30 minutes after product consumption, and 4 hours later.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTJoyRise Recovery PowderJoyRise Recovery Powder is a dietary supplement that contains Dihydromyricetin (DHM) and other natural ingredients. It is designed to mitigate the aftereffects of alcohol consumption. Participants will mix one serving in 8-12 oz of water and consume it the morning after alcohol consumption.
DIETARY_SUPPLEMENTPlaceboA placebo solution that is visually and tastefully similar to JoyRise Recovery Powder but contains no active ingredients. It will be mixed in 8-12 oz of water and consumed the morning after alcohol consumption.

Timeline

Start date
2024-06-25
Primary completion
2024-08-01
Completion
2024-08-01
First posted
2024-08-28
Last updated
2024-08-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06575972. Inclusion in this directory is not an endorsement.